Related Experiment Video
Updated: Mar 25, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.0K
[THE JAPANESE VERSION OF TOPICOP SCALE AMONG PATIENTS WITH ATOPIC DERMATITIS: A TRANSLATION AND FEASIBILITY STUDY]
Masaki Futamura1, Kiwako Yamamoto-Hanada, Mayako Saito
1Division of Allergy, National Center for Chilld Health and Development.
Arerugi = [Allergy]
|March 1, 2016
Summary
The Japanese TOPICOP scale effectively assesses fears about topical corticosteroids in atopic dermatitis patients. This validated tool is quick, easy to use, and suitable for clinical practice and research.
Area of Science:
- Dermatology
- Psychometrics
- Health Psychology
Context:
- Atopic dermatitis (AD) management often involves topical corticosteroids.
- Patient beliefs and anxieties about topical corticosteroids can impact treatment adherence.
- The TOPICOP scale was previously developed to assess these concerns in English-speaking populations.
Purpose:
- To translate the TOPICOP scale into Japanese.
- To evaluate the feasibility and psychometric properties of the Japanese version of the TOPICOP scale.
- To assess patient and parent worries and beliefs regarding topical corticosteroid use in Japanese atopic dermatitis patients.
Summary:
- A Japanese version of the TOPICOP scale was created through forward and backward translation.
- A survey of 287 participants (83% female, age 38±7) assessed the feasibility of the Japanese TOPICOP.
- Results indicated high rates of misconceptions about topical corticosteroids (e.g., entering bloodstream, damaging skin) and anxiety regarding application.
Impact:
- The Japanese TOPICOP scale is a feasible, quick, and easy-to-understand tool for evaluating corticosteroid phobia in Japanese AD patients.
- This validated scale can be utilized in clinical settings to address patient concerns.
- It provides a valuable resource for future clinical research on atopic dermatitis and topical corticosteroid use.
